fosinopril has been researched along with carvedilol in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (75.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Estelberger, W; Holzer, H; Oettl, K; Reibnegger, G; Stoschitzky, K; Zitta, S; Zweiker, R | 1 |
| Clark, AL; Cleland, JG; Coletta, AP; Freemantle, N | 1 |
| Belenkov, IuN; Belianko, IE; Dolotov, VK; Gerasimova, VV; Khovrin, VV; Konstantinov, BA; Koroteev, AV; Kulagina, TIu; Mareev, VIu; Rebunenkov, GV; Sandrikov, VA; Skvortsov, AA; Sychev, AV; Tereshchenko, SN | 1 |
| Nikitin, AV; Rakov, AL; Riabov, AIu | 1 |
| Gao, J; He, H; Ma, L; Wang, P; Wang, W; Wu, H; Zhang, H | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
1 review(s) available for fosinopril and carvedilol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 trial(s) available for fosinopril and carvedilol
| Article | Year |
|---|---|
Dynamic renal function testing by compartmental analysis: assessment of renal functional reserve in essential hypertension.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Carbazoles; Carvedilol; Dietary Proteins; Female; Fosinopril; Glomerular Filtration Rate; Humans; Hypertension; Kidney; Kidney Function Tests; Male; Middle Aged; Oligosaccharides; p-Aminohippuric Acid; Propanolamines; Reference Values; Renal Circulation; Vascular Resistance | 2000 |
[Evaluation of the effectivenes of treatment of patients with renal arterial hypertension with carvedilol].
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Carbazoles; Carvedilol; Female; Fosinopril; Humans; Hypercholesterolemia; Hypertension, Renal; Kidney Failure, Chronic; Male; Propanolamines; Treatment Outcome; Vasodilator Agents | 2006 |
5 other study(ies) available for fosinopril and carvedilol
| Article | Year |
|---|---|
Clinical trials update from the European Society of Cardiology Heart Failure meeting: SHAPE, BRING-UP 2 VAS, COLA II, FOSIDIAL, BETACAR, CASINO and meta-analysis of cardiac resynchronisation therapy.
Topics: Adrenergic beta-Antagonists; Betaxolol; Carbazoles; Cardiac Pacing, Artificial; Carvedilol; Clinical Trials as Topic; Europe; Fosinopril; Heart Failure; Humans; Meta-Analysis as Topic; Propanolamines | 2004 |
[Implantation of an extracardiac mesh in the treatment of dilated cardiomyopathy: the TOLK Study (Therapevticheskoe Operativnoe Lechenie Kardiomyopatye)].
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Diuretics; Female; Fosinopril; Humans; Intra-Aortic Balloon Pumping; Male; Middle Aged; Postoperative Care; Propanolamines; Quality of Life; Radiography, Thoracic; Spironolactone; Surgical Mesh; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Vasodilator Agents; Ventricular Remodeling | 2005 |
Fosinopril and carvedilol reverse hypertrophy and change the levels of protein kinase C epsilon and components of its signaling complex.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Carbazoles; Cardiomegaly; Carvedilol; Fosinopril; Heart Failure; Lung; Male; Myocardium; Propanolamines; Protein Kinase C-epsilon; Proteomics; Rats; Rats, Sprague-Dawley; Signal Transduction | 2006 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |